North America Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

List of Tables

The blood irradiation market in North America is expected to grow from US$ 29.02 million in 2022 to US$ 42.61 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028.

Increase in Communicable and Noncommunicable Disease Prevalence Favors North America Blood

Irradiation Market Growth

In North America, there has been a rise in the incidence of blood transfusion procedures owing to the surge in surgical procedures, accidents, trauma cases, and disorders; and the rising prevalence of bloodstream infections. Bloodstream infections are the major cause of illness and death among large populations. Bloodstream infections, as well as underlying conditions, and invasive procedures are common among the geriatric population. The rising awareness about these infections and elevated immune response to transfused blood can lead to complications. There is a high prevalence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, in North American countries. Blood transfusion may be a common step adopted during the treatment of these diseases. Cellular blood components are irradiated before undertaking the transfusion process. The irradiation prevents transfusion associated-graft versus host disease (TA-GVHD) among recipients by averting the proliferation of viable T lymphocytes. The increasing use of irradiated blood for the treatment of cancer patients strengthens the immune system and improves overall health.

Market Overview

The North American blood irradiation market has been segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2022. The US accounts for a significant share of the blood irradiation market in North America. Increasing demand for organ transplantation followed by increasing prevalence of both communicable and non-communicable diseases is likely to increase the demand for blood irradiation market. The four major diseases responsible for the death in the United States are Cardiovascular diseases, Diabetes, Cancer and Chronic respiratory diseases. Thus, the increasing research and development in the country is anticipated to boost the US blood irradiation market growth during the forecast period.

North America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)

North America Blood Irradiation Market Segmentation

The North America blood irradiation market is segmented into type, indication, end user, and country.

Based on type, the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.

Based on indication, the North America blood irradiation market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors, and others. The acute leukemia segment held the largest market share in 2022.

Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.

Based on country, the North America blood irradiation market is segmented into the US, Canada, Mexico; the US dominated the market in 2022.

Hitachi, Ltd.; Best Theratronics Ltd.; Rad Source Technologies; Gilardoni S.p.A.; Typenex Medical, and Actemium are the leading companies operating in the blood irradiation market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Blood Irradiation Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America Blood Irradiation Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00027187

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Blood Irradiation Market - By Type
- 1.3.2 North America Blood Irradiation Market - By Indication
- 1.3.3 North America Blood Irradiation Market - By End User
- 1.3.4 North America Blood Irradiation Market - By Country

2. North America Blood Irradiation Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Blood Irradiation Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Experts Opinion

5. North America Blood Irradiation Market- Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Communicable and Noncommunicable Diseases
- 5.1.2 Rise in Healthcare Expenditure and Government Initiatives
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
5.3 Market Opportunities
- 5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia and Lymphoma
5.4 Future Trends
- 5.4.1 Technological Advancements and Product Launches
5.5 Impact Analysis

6. Blood Irradiation Market- North America Analysis

6.1 North America Blood Irradiation Market Revenue Forecasts and Analysis
- 6.1.1 Overview
- 6.1.2 North America Blood Irradiation Market, and Forecast to 2028 (Units)

7. North America Blood Irradiation Market Analysis - By Type

7.1 Overview
7.2 North America Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
- 7.2.1 North America: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
7.3 Intravenous Laser Blood Radiation
- 7.3.1 Overview
- 7.3.2 North America Intravenous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Transcutaneous Laser Blood Radiation
- 7.4.1 Overview
- 7.4.2 North America Transcutaneous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Extracorporeal Blood Radiation
- 7.5.1 Overview
- 7.5.2 North America Extracorporeal Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Blood Irradiation Market -By End User

8.1 Overview
8.2 North America Blood Irradiation Market, by End User, 2021 and 2028 (%)
- 8.2.1 North America: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 North America Hospitals: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Banks
- 8.4.1 Overview
- 8.4.2 North America Blood Banks: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Centers
- 8.5.1 Overview
- 8.5.2 North America Diagnostic Centers: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Research Institutes
- 8.6.1 Overview
- 8.6.2 North America Research Institutes: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Blood Irradiation Market -By Indication

9.1 Overview
9.2 North America Blood Irradiation Market, by Indication, 2021 and 2028 (%)
- 9.2.1 North America: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
9.3 Acute Leukemia
- 9.3.1 Overview
- 9.3.2 North America Acute Leukemia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Solid Tumors
- 9.4.1 Overview
- 9.4.2 North America Solid Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Pelvic Tumors
- 9.5.1 Overview
- 9.5.2 North America Pelvic Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Lymphoma
- 9.6.1 Overview
- 9.6.2 North America Lymphoma: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 North America Others: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Blood Irradiation Market - Country Analysis

10.1 North America: Blood Irradiation Market
- 10.1.1 Overview
- 10.1.2 North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  - 10.1.2.1 US: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 US: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.1.4 US: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.1.5 US: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.2 Canada: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Canada: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.2.4 Canada: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.2.5 Canada: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.3 Mexico: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Mexico: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.3.4 Mexico: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.3.5 Mexico: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)

11. North America Blood Irradiation Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the North America Blood Irradiation Market, 2021-2028
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Hitachi, Ltd.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Best Theratronics Ltd.,
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Rad Source Technologies
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Gilardoni S.p.A.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Typenex Medical
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Actemium
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms